US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

9.16

-0.2400-2.55%

Post-market: 9.390.2300+2.51%19:55 EDT

Volume:791.68K

Turnover:7.30M

Market Cap:488.70M

PE:3.62

High:9.62

Open:9.30

Low:9.04

Close:9.40

52wk High:12.73

52wk Low:4.02

Shares:53.35M

Float Shares:48.26M

Volume Ratio:0.99

T/O Rate:1.64%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.53

EPS(LYR):-3.5962

ROE:30.24%

ROA:5.03%

PB:0.91

PE(LYR):-2.55

Loading ...

Overview Company News Filings

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

Aptevo Therapeutics Inc. Conducted Annual Stockholder Meeting

Emergent BioSolutions Inc. to Announce Second Quarter 2025 Financial Results

Aptevo Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Dirk Huebner, SVP and CMO

Emergent BioSolutions Shares Rise Over 6% After HHS Contract Modification

Emergent BioSolutions Secures $51.9 Million Contract for Smallpox Treatment with U.S. Government

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Aptevo Therapeutics Appoints Baker Tilly as New Auditor Following Moss Adams Merger

BUZZ-Emergent rises as US awards additional $62.4 million for botulism treatment stockpile

Emergent BioSolutions Secures $62.4 Million Contract to Supply Botulism Antitoxin to U.S

Aptevo Therapeutics Expands CD3 Portfolio with New APVO455 Candidate Targeting Solid Tumors

Emergent BioSolutions Inc. Joins Russell 3000® Index

Aptevo Therapeutics Announces $8 Million At-the-Market Offering Under Nasdaq Rules

Aptevo Therapeutics Announces Promising Phase 1b/2 Trial Results for Mipletamig in Frontline AML, Achieving 85% Remission Rate Without Added Toxicity

Aptevo Therapeutics Inc. Enters Standby Equity Purchase Agreement for Up to $25 Million in Common Stock Sales with Yorkville

Aptevo Therapeutics Inc. Announces Participation in BIO International Convention in Boston

Emergent BioSolutions Faces Derivative Litigation Over Alleged Breaches of Fiduciary Duty and Regulatory Failures

Director Keith Katkin Reports Disposal of Common Shares of Emergent BioSolutions Inc

Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split Effective May 23, 2025

Emergent BioSolutions Faces Multiple Lawsuits Over Securities Fraud and Manufacturing Failures

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/EBS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EBS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EBS\",,,,,undefined,":{"symbol":"EBS","market":"US","secType":"STK","nameCN":"Emergent BioSolutions","latestPrice":9.16,"timestamp":1760731200000,"preClose":9.4,"halted":0,"volume":791678,"hourTrading":{"tag":"盘后","latestPrice":9.39,"preClose":9.16,"latestTime":"19:55 EDT","volume":20115,"amount":184369.4914,"timestamp":1760745336011},"delay":0,"floatShares":48259238,"shares":53351099,"eps":2.527379,"marketStatus":"Market Closed","change":-0.24,"latestTime":"10-17 16:00:00 EDT","open":9.3,"high":9.6199,"low":9.04,"amount":7295147.309298,"amplitude":0.061691,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.527379,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1254456000000,"exchange":"NYSE","adjPreClose":9.4,"preHourTrading":{"tag":"盘前","latestPrice":9.12,"preClose":9.4,"latestTime":"08:39 EDT","volume":1712,"amount":15840.666911999999,"timestamp":1760704792453},"postHourTrading":{"tag":"盘后","latestPrice":9.39,"preClose":9.16,"latestTime":"19:55 EDT","volume":20115,"amount":184369.4914,"timestamp":1760745336011},"volumeRatio":0.9866705420712799,"impliedVol":0.9741,"impliedVolPercentile":0.732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EBS\",,,,,undefined,":{"symbol":"EBS","floatShares":48259238,"roa":"5.03%","roe":"30.24%","lyrEps":-3.596226,"volumeRatio":0.9866705420712799,"shares":53351099,"dividePrice":0,"high":9.6199,"amplitude":0.061691,"preClose":9.4,"low":9.04,"week52Low":4.02,"pbRate":"0.91","psRate":"0.57","week52High":12.73,"institutionHeld":0.7402,"latestPrice":9.16,"eps":2.527379,"divideRate":0,"volume":791678,"delay":0,"ttmEps":2.527379,"open":9.3,"prevYearClose":9.56,"prevWeekClose":9.07,"prevMonthClose":8.82,"prevQuarterClose":8.82,"fiveDayClose":9.07,"twentyDayClose":8.21,"sixtyDayClose":7.47,"earningDate":1761667200000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EBS\",params:#limit:5,,,undefined,":[{"date":"2025-10-29","symbol":"EBS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":-0.01,"defaultRemindTime":1761768000000,"name":null,"time":"Post Market","dateTimestamp":1761710400000,"actualEps":null},{"market":"US","date":"2025-08-06","symbol":"EBS","fiscalQuarterEnding":"2025/06","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.16},{"market":"US","date":"2025-05-07","symbol":"EBS","fiscalQuarterEnding":"2025/03","expectedEps":0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":0.71},{"market":"US","date":"2025-03-03","symbol":"EBS","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2024-11-06","symbol":"EBS","fiscalQuarterEnding":"2024/09","expectedEps":0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":1.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EBS\",market:\"US\",,,undefined,":[{"executeDate":"2016-08-01","recordDate":null,"paymentDate":null,"value":0,"currency":""}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EBS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0,"sell":0.3333,"strongSell":0,"meanLabel":"HOLD","meanPercent":0,"analysts":3,"updateTime":1735704000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EBS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EBS","date":"2025-10-17","current":3.624308,"percent":0.514658,"low":-3.159332,"twenty":-1.085009,"median":3.373166,"eighty":11.236675,"high":39.825704,"avg":6.149767,"sd":8.932211,"marketCap":501500330},"quantilePoints":[{"date":"2020-10-23","current":29.868532,"twenty":22.905433,"median":34.357442,"eighty":60.989072,"marketCap":5086611081},{"date":"2020-10-30","current":27.960377,"twenty":22.905433,"median":34.082745,"eighty":60.314666,"marketCap":4761652263},{"date":"2020-11-06","current":29.362668,"twenty":22.905433,"median":33.939769,"eighty":59.678965,"marketCap":4891820529},{"date":"2020-11-13","current":27.597091,"twenty":22.905433,"median":33.655439,"eighty":59.183694,"marketCap":4597675308},{"date":"2020-11-20","current":26.295971,"twenty":22.905433,"median":33.396003,"eighty":58.733282,"marketCap":4380908829},{"date":"2020-11-27","current":26.350052,"twenty":22.905433,"median":33.268263,"eighty":58.334767,"marketCap":4389918683},{"date":"2020-12-04","current":26.337327,"twenty":22.905433,"median":33.181537,"eighty":58.079634,"marketCap":4387798717},{"date":"2020-12-11","current":26.620456,"twenty":22.905433,"median":33.103703,"eighty":57.521175,"marketCap":4434967951},{"date":"2020-12-18","current":30.657425,"twenty":22.905433,"median":32.912329,"eighty":57.279098,"marketCap":5107527025},{"date":"2020-12-24","current":29.852576,"twenty":22.905433,"median":32.810121,"eighty":57.110645,"marketCap":4973439203},{"date":"2020-12-31","current":28.503739,"twenty":22.905433,"median":32.756577,"eighty":56.46771,"marketCap":4748722854},{"date":"2021-01-08","current":30.93101,"twenty":22.905433,"median":32.678739,"eighty":56.068088,"marketCap":5153106284},{"date":"2021-01-15","current":33.813196,"twenty":22.905433,"median":32.653366,"eighty":55.878419,"marketCap":5633278484},{"date":"2021-01-22","current":34.077238,"twenty":22.905433,"median":32.653366,"eighty":55.398303,"marketCap":5677267769},{"date":"2021-01-29","current":33.991345,"twenty":22.905433,"median":32.653366,"eighty":55.221138,"marketCap":5662958002},{"date":"2021-02-05","current":37.395251,"twenty":22.905433,"median":32.653366,"eighty":54.838418,"marketCap":6230048789},{"date":"2021-02-12","current":39.825704,"twenty":22.905433,"median":32.653366,"eighty":54.706903,"marketCap":6634962211},{"date":"2021-02-19","current":18.00076,"twenty":22.858408,"median":32.617696,"eighty":54.608679,"marketCap":5492032000},{"date":"2021-02-26","current":16.770895,"twenty":22.715233,"median":32.521364,"eighty":54.321797,"marketCap":5116800000},{"date":"2021-03-05","current":16.126264,"twenty":22.533347,"median":32.412988,"eighty":53.889944,"marketCap":4920123000},{"date":"2021-03-12","current":15.755906,"twenty":22.132732,"median":32.367492,"eighty":53.613144,"marketCap":4807127000},{"date":"2021-03-19","current":15.893917,"twenty":21.550848,"median":32.235135,"eighty":53.467396,"marketCap":4849234000},{"date":"2021-03-26","current":16.51409,"twenty":21.184535,"median":32.110568,"eighty":53.290468,"marketCap":5038449000},{"date":"2021-04-01","current":14.056106,"twenty":21.094688,"median":32.044431,"eighty":52.895271,"marketCap":4288518000},{"date":"2021-04-09","current":13.583006,"twenty":20.996841,"median":31.942999,"eighty":52.313721,"marketCap":4144175148},{"date":"2021-04-16","current":13.633931,"twenty":20.846697,"median":31.86991,"eighty":51.640939,"marketCap":4159712457},{"date":"2021-04-23","current":10.876941,"twenty":20.780465,"median":31.797859,"eighty":50.050738,"marketCap":3318554734},{"date":"2021-04-30","current":8.43698,"twenty":20.639112,"median":31.744272,"eighty":49.556131,"marketCap":3267642448},{"date":"2021-05-07","current":8.525528,"twenty":20.559,"median":31.688361,"eighty":49.306144,"marketCap":3301937154},{"date":"2021-05-14","current":8.578104,"twenty":20.500612,"median":31.615561,"eighty":49.306144,"marketCap":3322299636},{"date":"2021-05-21","current":8.093856,"twenty":20.427881,"median":31.528606,"eighty":49.306144,"marketCap":3134750463},{"date":"2021-05-28","current":8.391323,"twenty":20.333599,"median":31.476416,"eighty":49.203627,"marketCap":3249959240},{"date":"2021-06-04","current":8.91016,"twenty":20.28879,"median":31.412082,"eighty":48.595088,"marketCap":3450904783},{"date":"2021-06-11","current":8.787022,"twenty":20.124492,"median":31.323208,"eighty":47.338871,"marketCap":3403213707},{"date":"2021-06-18","current":8.377487,"twenty":19.999571,"median":31.27214,"eighty":47.338871,"marketCap":3244600692},{"date":"2021-06-25","current":8.767652,"twenty":19.923532,"median":31.206772,"eighty":47.338871,"marketCap":3395711740},{"date":"2021-07-02","current":8.821611,"twenty":19.727492,"median":31.094988,"eighty":47.338871,"marketCap":3416610077},{"date":"2021-07-09","current":8.322144,"twenty":19.654882,"median":30.995375,"eighty":47.338871,"marketCap":3223166501},{"date":"2021-07-16","current":8.637597,"twenty":19.559873,"median":30.94408,"eighty":47.338871,"marketCap":3345341391},{"date":"2021-07-23","current":8.908776,"twenty":19.425639,"median":30.878179,"eighty":47.338871,"marketCap":3450368928},{"date":"2021-07-30","current":11.827801,"twenty":19.217457,"median":30.796558,"eighty":47.338871,"marketCap":3538878041},{"date":"2021-08-06","current":10.914242,"twenty":18.102674,"median":30.695603,"eighty":47.338871,"marketCap":3265541330},{"date":"2021-08-13","current":11.052443,"twenty":17.640066,"median":30.592904,"eighty":47.338871,"marketCap":3306890891},{"date":"2021-08-20","current":11.348587,"twenty":16.870845,"median":30.529667,"eighty":47.338871,"marketCap":3395497094},{"date":"2021-08-27","current":11.515504,"twenty":16.688203,"median":30.466552,"eighty":47.338871,"marketCap":3445438772},{"date":"2021-09-03","current":11.344997,"twenty":16.580475,"median":30.347125,"eighty":47.338871,"marketCap":3394423080},{"date":"2021-09-10","current":10.246573,"twenty":16.392821,"median":30.224779,"eighty":47.338871,"marketCap":3065774618},{"date":"2021-09-17","current":10.255547,"twenty":16.225492,"median":30.054997,"eighty":47.338871,"marketCap":3068459655},{"date":"2021-09-24","current":9.403012,"twenty":16.050445,"median":29.868532,"eighty":47.338871,"marketCap":2813381192},{"date":"2021-10-01","current":9.873252,"twenty":15.943723,"median":29.825024,"eighty":47.338871,"marketCap":2954077102},{"date":"2021-10-08","current":9.415576,"twenty":15.871883,"median":29.744704,"eighty":47.338871,"marketCap":2817140243},{"date":"2021-10-15","current":9.097894,"twenty":15.76757,"median":29.492939,"eighty":47.338871,"marketCap":2722089953},{"date":"2021-10-22","current":8.94713,"twenty":15.708234,"median":29.351857,"eighty":47.338871,"marketCap":2676981340},{"date":"2021-10-29","current":8.555861,"twenty":15.509423,"median":29.270465,"eighty":47.338871,"marketCap":2559913751},{"date":"2021-11-05","current":7.847021,"twenty":15.046217,"median":29.21776,"eighty":47.338871,"marketCap":1781273765},{"date":"2021-11-12","current":8.754725,"twenty":14.887731,"median":29.19113,"eighty":47.338871,"marketCap":1987322648},{"date":"2021-11-19","current":9.496531,"twenty":14.777403,"median":29.19113,"eighty":47.338871,"marketCap":2155712466},{"date":"2021-11-26","current":10.477705,"twenty":14.619815,"median":29.19113,"eighty":47.338871,"marketCap":2378438935},{"date":"2021-12-03","current":9.927868,"twenty":14.501121,"median":29.19113,"eighty":47.338871,"marketCap":2253626034},{"date":"2021-12-10","current":9.491791,"twenty":14.046462,"median":29.19113,"eighty":47.338871,"marketCap":2154636493},{"date":"2021-12-17","current":10.674413,"twenty":13.823212,"median":29.19113,"eighty":47.338871,"marketCap":2423091826},{"date":"2021-12-23","current":10.788173,"twenty":13.731869,"median":29.19113,"eighty":47.338871,"marketCap":2448915185},{"date":"2021-12-31","current":10.302326,"twenty":13.478346,"median":29.19113,"eighty":47.338871,"marketCap":2338627924},{"date":"2022-01-07","current":11.560788,"twenty":12.340291,"median":29.177815,"eighty":47.336592,"marketCap":2624298829},{"date":"2022-01-14","current":12.376063,"twenty":11.807578,"median":29.177815,"eighty":47.336592,"marketCap":2809366234},{"date":"2022-01-21","current":11.13182,"twenty":11.557834,"median":29.177815,"eighty":47.336592,"marketCap":2526923248},{"date":"2022-01-28","current":10.736033,"twenty":11.457998,"median":29.177815,"eighty":47.336592,"marketCap":2437079479},{"date":"2022-02-04","current":10.736033,"twenty":11.379816,"median":29.177815,"eighty":47.336592,"marketCap":2437079479},{"date":"2022-02-11","current":10.840312,"twenty":11.313408,"median":29.177815,"eighty":47.336592,"marketCap":2460750891},{"date":"2022-02-18","current":9.911278,"twenty":11.228501,"median":29.177815,"eighty":47.336592,"marketCap":2249860128},{"date":"2022-02-25","current":8.669884,"twenty":11.145729,"median":29.177815,"eighty":47.336592,"marketCap":2001876328},{"date":"2022-03-04","current":9.09638,"twenty":11.060961,"median":29.177815,"eighty":47.336592,"marketCap":2100354099},{"date":"2022-03-11","current":7.978743,"twenty":10.987282,"median":29.177815,"eighty":47.336592,"marketCap":1842291838},{"date":"2022-03-18","current":9.352277,"twenty":10.90814,"median":29.177815,"eighty":47.336592,"marketCap":2159440761},{"date":"2022-03-25","current":9.667227,"twenty":10.847766,"median":29.177815,"eighty":47.336592,"marketCap":2232162808},{"date":"2022-04-01","current":9.54256,"twenty":10.814242,"median":29.177815,"eighty":47.336592,"marketCap":2203376998},{"date":"2022-04-08","current":9.105128,"twenty":10.736033,"median":29.177815,"eighty":47.336592,"marketCap":2102374156},{"date":"2022-04-14","current":9.054824,"twenty":10.689581,"median":29.177815,"eighty":47.336592,"marketCap":2090758829},{"date":"2022-04-22","current":8.14159,"twenty":10.58862,"median":29.177815,"eighty":47.336592,"marketCap":1879893050},{"date":"2022-04-29","current":10.329451,"twenty":10.496676,"median":29.177815,"eighty":47.336592,"marketCap":1626888545},{"date":"2022-05-06","current":10.039155,"twenty":10.481497,"median":29.177815,"eighty":47.336592,"marketCap":1581166847},{"date":"2022-05-13","current":9.168265,"twenty":10.312286,"median":29.177815,"eighty":47.336592,"marketCap":1444001753},{"date":"2022-05-20","current":11.270522,"twenty":10.290872,"median":29.177815,"eighty":47.336592,"marketCap":1775107235},{"date":"2022-05-27","current":11.235431,"twenty":10.272564,"median":29.177815,"eighty":47.336592,"marketCap":1769580437},{"date":"2022-06-03","current":10.28479,"twenty":10.267564,"median":29.177815,"eighty":47.336592,"marketCap":1619854437},{"date":"2022-06-10","current":9.541503,"twenty":10.243504,"median":29.177815,"eighty":47.336592,"marketCap":1502786793},{"date":"2022-06-17","current":9.107654,"twenty":10.106696,"median":29.177815,"eighty":47.336592,"marketCap":1434455465},{"date":"2022-06-24","current":10.450674,"twenty":10.073859,"median":29.19113,"eighty":47.338871,"marketCap":1645981122},{"date":"2022-07-01","current":10.153997,"twenty":10.044897,"median":29.19113,"eighty":47.338871,"marketCap":1599254551},{"date":"2022-07-08","current":10.74735,"twenty":10.044897,"median":29.19113,"eighty":47.338871,"marketCap":1692707692},{"date":"2022-07-15","current":9.739288,"twenty":10.005603,"median":29.19113,"eighty":47.338871,"marketCap":1533937840},{"date":"2022-07-22","current":9.968973,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1570113250},{"date":"2022-07-29","current":11.050407,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1740439135},{"date":"2022-08-05","current":16.353542,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1578116759},{"date":"2022-08-12","current":15.759337,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1520776024},{"date":"2022-08-19","current":14.524425,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1401607017},{"date":"2022-08-26","current":13.237843,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1277451860},{"date":"2022-09-02","current":11.889257,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1147313322},{"date":"2022-09-09","current":12.953658,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1250028030},{"date":"2022-09-16","current":11.858255,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1144321631},{"date":"2022-09-23","current":10.778353,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1040111077},{"date":"2022-09-30","current":10.845524,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":1046593073},{"date":"2022-10-07","current":10.080809,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":972798040},{"date":"2022-10-14","current":10.039473,"twenty":9.983923,"median":29.19113,"eighty":47.338871,"marketCap":968809119},{"date":"2022-10-21","current":9.641614,"twenty":9.962011,"median":29.19113,"eighty":47.338871,"marketCap":930415757},{"date":"2022-10-28","current":11.083206,"twenty":9.921232,"median":29.19113,"eighty":47.338871,"marketCap":1069529368},{"date":"2022-11-04","current":10.313324,"twenty":9.921232,"median":29.164499,"eighty":47.338871,"marketCap":995235719},{"date":"2022-11-11","current":14.677393,"twenty":9.921232,"median":28.914455,"eighty":47.338871,"marketCap":785240551},{"date":"2022-11-18","current":11.488277,"twenty":9.921232,"median":28.822745,"eighty":47.338871,"marketCap":614622845},{"date":"2022-11-25","current":11.096632,"twenty":9.921232,"median":28.732423,"eighty":47.338871,"marketCap":593669794},{"date":"2022-12-02","current":11.189881,"twenty":9.921232,"median":28.557018,"eighty":47.338871,"marketCap":598658616},{"date":"2022-12-09","current":11.292455,"twenty":9.921232,"median":28.405121,"eighty":47.338871,"marketCap":604146319},{"date":"2022-12-16","current":10.537138,"twenty":9.921232,"median":28.268449,"eighty":47.338871,"marketCap":563736863},{"date":"2022-12-23","current":10.257391,"twenty":9.921232,"median":28.098703,"eighty":47.338871,"marketCap":548770398},{"date":"2022-12-30","current":11.012708,"twenty":9.921232,"median":27.945931,"eighty":47.338871,"marketCap":589179854},{"date":"2023-01-06","current":12.644565,"twenty":9.921232,"median":27.945931,"eighty":47.338871,"marketCap":676484236},{"date":"2023-01-13","current":12.523341,"twenty":9.921232,"median":27.945931,"eighty":47.338871,"marketCap":669998767},{"date":"2023-01-20","current":12.560641,"twenty":9.921232,"median":27.786184,"eighty":47.338871,"marketCap":671994296},{"date":"2023-01-27","current":12.560641,"twenty":9.921232,"median":27.597091,"eighty":47.338871,"marketCap":671994296},{"date":"2023-02-03","current":13.026886,"twenty":9.921232,"median":27.517866,"eighty":47.338871,"marketCap":696938405},{"date":"2023-02-10","current":12.131696,"twenty":9.921232,"median":27.517866,"eighty":47.338871,"marketCap":649045716},{"date":"2023-02-17","current":15.190263,"twenty":9.921232,"median":27.39803,"eighty":47.338871,"marketCap":812679071},{"date":"2023-02-24","current":12.784439,"twenty":9.921232,"median":27.241269,"eighty":47.338871,"marketCap":683967468},{"date":"2023-03-03","current":-2.612307,"twenty":9.811416,"median":27.155703,"eighty":47.338871,"marketCap":584634242},{"date":"2023-03-10","current":-2.170948,"twenty":9.7227,"median":26.985262,"eighty":47.338871,"marketCap":485858131},{"date":"2023-03-17","current":-1.819205,"twenty":9.666358,"median":26.646815,"eighty":47.338871,"marketCap":407138082},{"date":"2023-03-24","current":-1.814724,"twenty":9.618647,"median":26.521838,"eighty":47.338871,"marketCap":406135279},{"date":"2023-03-31","current":-2.321055,"twenty":9.581449,"median":26.341206,"eighty":47.336592,"marketCap":519452036},{"date":"2023-04-06","current":-2.300891,"twenty":9.536984,"median":26.224394,"eighty":47.336592,"marketCap":514939422},{"date":"2023-04-14","current":-2.827385,"twenty":9.493687,"median":26.103507,"eighty":47.341151,"marketCap":632768793},{"date":"2023-04-21","current":-2.31049,"twenty":9.449758,"median":25.620861,"eighty":47.341151,"marketCap":517087686},{"date":"2023-04-28","current":-1.934416,"twenty":9.419421,"median":25.2533,"eighty":47.341151,"marketCap":432922341},{"date":"2023-05-05","current":-1.923156,"twenty":9.359508,"median":24.424325,"eighty":47.34343,"marketCap":430402421},{"date":"2023-05-12","current":-1.314034,"twenty":9.29614,"median":20.373274,"eighty":47.34343,"marketCap":529687289},{"date":"2023-05-19","current":-1.081295,"twenty":9.249362,"median":17.347394,"eighty":47.34343,"marketCap":435870011},{"date":"2023-05-26","current":-1.019972,"twenty":9.187803,"median":16.770895,"eighty":47.34343,"marketCap":411150531},{"date":"2023-06-02","current":-1.026229,"twenty":9.158097,"median":16.400538,"eighty":47.34343,"marketCap":413672927},{"date":"2023-06-09","current":-1.050008,"twenty":9.131574,"median":16.231082,"eighty":47.34343,"marketCap":423258032},{"date":"2023-06-16","current":-1.012463,"twenty":9.096683,"median":16.010964,"eighty":47.34343,"marketCap":408123656},{"date":"2023-06-22","current":-1.217708,"twenty":9.076695,"median":15.872108,"eighty":47.34571,"marketCap":490858242},{"date":"2023-06-30","current":-0.953642,"twenty":9.053074,"median":15.759337,"eighty":47.466565,"marketCap":384413135},{"date":"2023-07-07","current":-0.866037,"twenty":9.039386,"median":15.539739,"eighty":47.466565,"marketCap":349099592},{"date":"2023-07-14","current":-0.911091,"twenty":9.003301,"median":15.188032,"eighty":47.466565,"marketCap":367260843},{"date":"2023-07-21","current":-0.883558,"twenty":8.972872,"median":14.600909,"eighty":47.466565,"marketCap":356162301},{"date":"2023-07-28","current":-0.863534,"twenty":8.917642,"median":14.021729,"eighty":47.466565,"marketCap":348090634},{"date":"2023-08-04","current":-0.901079,"twenty":8.849836,"median":13.779397,"eighty":47.466565,"marketCap":363225009},{"date":"2023-08-11","current":-0.487395,"twenty":8.798644,"median":13.575368,"eighty":47.466565,"marketCap":296336194},{"date":"2023-08-18","current":-0.43627,"twenty":8.742633,"median":13.112687,"eighty":47.466565,"marketCap":265251978},{"date":"2023-08-25","current":-0.385996,"twenty":8.674677,"median":12.984924,"eighty":47.466565,"marketCap":234685832},{"date":"2023-09-01","current":-0.39963,"twenty":8.634277,"median":12.771386,"eighty":47.466565,"marketCap":242974956},{"date":"2023-09-08","current":-0.372363,"twenty":8.559256,"median":12.680271,"eighty":47.466565,"marketCap":226396707},{"date":"2023-09-15","current":-0.352765,"twenty":8.540988,"median":12.555979,"eighty":47.466565,"marketCap":214481091},{"date":"2023-09-22","current":-0.293119,"twenty":8.520271,"median":12.428619,"eighty":47.466565,"marketCap":178216172},{"date":"2023-09-29","current":-0.282042,"twenty":8.429786,"median":12.360155,"eighty":47.466565,"marketCap":171481259},{"date":"2023-10-06","current":-0.253071,"twenty":8.363034,"median":12.246766,"eighty":47.466565,"marketCap":153866870},{"date":"2023-10-13","current":-0.224099,"twenty":8.3177,"median":12.103721,"eighty":47.466565,"marketCap":136252481},{"date":"2023-10-20","current":-0.189164,"twenty":8.179461,"median":11.916684,"eighty":47.466565,"marketCap":115011599},{"date":"2023-10-27","current":-0.183199,"twenty":8.142281,"median":11.88409,"eighty":47.647847,"marketCap":111385108},{"date":"2023-11-03","current":-0.180643,"twenty":8.106308,"median":11.739414,"eighty":47.647847,"marketCap":109830897},{"date":"2023-11-10","current":-0.183199,"twenty":8.0565,"median":11.646801,"eighty":47.647847,"marketCap":111385108},{"date":"2023-11-17","current":-0.14357,"twenty":7.948582,"median":11.546016,"eighty":47.647847,"marketCap":109830897},{"date":"2023-11-24","current":-0.141538,"twenty":7.832362,"median":11.516252,"eighty":47.647847,"marketCap":108276686},{"date":"2023-12-01","current":-0.144924,"twenty":-0.140184,"median":11.458878,"eighty":47.647847,"marketCap":110867037},{"date":"2023-12-08","current":-0.163886,"twenty":-0.143299,"median":11.423109,"eighty":47.58742,"marketCap":125373005},{"date":"2023-12-15","current":-0.166119,"twenty":-0.145601,"median":11.367054,"eighty":47.58742,"marketCap":131267526},{"date":"2023-12-22","current":-0.150361,"twenty":-0.152987,"median":11.30706,"eighty":47.58742,"marketCap":118815271},{"date":"2023-12-29","current":-0.16218,"twenty":-0.16021,"median":11.270522,"eighty":47.647847,"marketCap":128154463},{"date":"2024-01-05","current":-0.157387,"twenty":-0.16192,"median":11.248974,"eighty":47.706641,"marketCap":122447179},{"date":"2024-01-12","current":-0.140048,"twenty":-0.16192,"median":11.221981,"eighty":47.706641,"marketCap":108957235},{"date":"2024-01-19","current":-0.122709,"twenty":-0.161985,"median":11.17922,"eighty":47.765435,"marketCap":95467292},{"date":"2024-01-26","current":-0.124042,"twenty":-0.16192,"median":11.105957,"eighty":47.706641,"marketCap":96504980},{"date":"2024-02-02","current":-0.110038,"twenty":-0.16192,"median":11.075456,"eighty":47.706641,"marketCap":85609256},{"date":"2024-02-09","current":-0.112038,"twenty":-0.16192,"median":11.048533,"eighty":47.706641,"marketCap":87165788},{"date":"2024-02-16","current":-0.113372,"twenty":-0.16192,"median":11.023187,"eighty":47.706641,"marketCap":88203476},{"date":"2024-02-23","current":-0.18673,"twenty":-0.162593,"median":10.997765,"eighty":47.336592,"marketCap":145276314},{"date":"2024-03-01","current":-0.215407,"twenty":-0.168627,"median":10.969532,"eighty":46.684274,"marketCap":167586605},{"date":"2024-03-08","current":-0.19013,"twenty":-0.174045,"median":10.914242,"eighty":43.908643,"marketCap":144594000},{"date":"2024-03-15","current":-0.161312,"twenty":-0.180643,"median":10.876941,"eighty":43.752727,"marketCap":122678067},{"date":"2024-03-22","current":-0.16955,"twenty":-0.180643,"median":10.833476,"eighty":43.752727,"marketCap":128942479},{"date":"2024-03-28","current":-0.177787,"twenty":-0.180643,"median":10.816612,"eighty":43.752727,"marketCap":135206891},{"date":"2024-04-05","current":-0.155821,"twenty":-0.18066,"median":10.780936,"eighty":43.765881,"marketCap":118501792},{"date":"2024-04-12","current":-0.150329,"twenty":-0.18066,"median":10.755326,"eighty":43.582483,"marketCap":114325518},{"date":"2024-04-19","current":-0.128135,"twenty":-0.18066,"median":10.736033,"eighty":43.385804,"marketCap":97446821},{"date":"2024-04-26","current":-0.134335,"twenty":-0.180643,"median":10.693373,"eighty":41.935904,"marketCap":102161989},{"date":"2024-05-03","current":-0.305891,"twenty":-0.180728,"median":10.650713,"eighty":40.748746,"marketCap":172920000},{"date":"2024-05-10","current":-0.405088,"twenty":-0.18673,"median":10.610177,"eighty":39.825704,"marketCap":228996084},{"date":"2024-05-17","current":-0.488515,"twenty":-0.19013,"median":10.570134,"eighty":39.202184,"marketCap":276157749},{"date":"2024-05-24","current":-0.457925,"twenty":-0.206206,"median":10.489001,"eighty":38.1492,"marketCap":258865139},{"date":"2024-05-31","current":-0.47183,"twenty":-0.213874,"median":10.476194,"eighty":37.532043,"marketCap":266725416},{"date":"2024-06-07","current":-0.580286,"twenty":-0.224099,"median":10.406589,"eighty":36.786372,"marketCap":328035581},{"date":"2024-06-14","current":-0.559892,"twenty":-0.250344,"median":10.372308,"eighty":34.836913,"marketCap":316507174},{"date":"2024-06-21","current":-0.599752,"twenty":-0.260228,"median":10.316691,"eighty":34.536059,"marketCap":339039969},{"date":"2024-06-28","current":-0.647028,"twenty":-0.270112,"median":10.307825,"eighty":34.245842,"marketCap":365764913},{"date":"2024-07-05","current":-0.698939,"twenty":-0.282042,"median":10.294953,"eighty":33.997707,"marketCap":395109949},{"date":"2024-07-12","current":-0.916777,"twenty":-0.316125,"median":10.267831,"eighty":33.71776,"marketCap":518254296},{"date":"2024-07-15","current":-0.987227,"twenty":-0.320386,"median":10.264641,"eighty":33.243543,"marketCap":558079702},{"date":"2024-08-02","current":-0.979812,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":553887554},{"date":"2024-08-09","current":-0.757096,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":444415641},{"date":"2024-08-16","current":-0.78053,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":458171363},{"date":"2024-08-23","current":-0.85624,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":502612928},{"date":"2024-08-30","current":-0.803063,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":471398019},{"date":"2024-09-06","current":-0.687696,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":403677541},{"date":"2024-09-13","current":-0.687696,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":403677541},{"date":"2024-09-20","current":-0.64327,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":377599534},{"date":"2024-09-27","current":-0.669958,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":393265323},{"date":"2024-10-04","current":-0.822723,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":482938460},{"date":"2024-10-11","current":-0.77763,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":456468678},{"date":"2024-10-18","current":-0.841129,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":493742452},{"date":"2024-10-25","current":-0.833766,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":489420855},{"date":"2024-10-31","current":-0.883461,"twenty":-0.343392,"median":10.231226,"eighty":32.090259,"marketCap":518591635},{"date":"2024-11-08","current":-2.845879,"twenty":-0.349527,"median":10.181113,"eighty":31.909078,"marketCap":594219582},{"date":"2024-11-15","current":-2.405591,"twenty":-0.371678,"median":10.120064,"eighty":31.42938,"marketCap":502287404},{"date":"2024-11-22","current":-2.439326,"twenty":-0.386678,"median":10.092265,"eighty":31.049475,"marketCap":509331348},{"date":"2024-11-29","current":-2.626168,"twenty":-0.397755,"median":10.072437,"eighty":30.81186,"marketCap":548343962},{"date":"2024-12-06","current":-2.374451,"twenty":-0.408611,"median":10.039314,"eighty":30.53794,"marketCap":495785301},{"date":"2024-12-13","current":-2.255079,"twenty":-0.435588,"median":9.982876,"eighty":30.237504,"marketCap":470860576},{"date":"2024-12-20","current":-2.091593,"twenty":-0.454787,"median":9.919573,"eighty":29.865341,"marketCap":436724539},{"date":"2024-12-27","current":-2.185014,"twenty":-0.470282,"median":9.849336,"eighty":29.616472,"marketCap":456230846},{"date":"2025-01-03","current":-2.665094,"twenty":-0.488291,"median":9.750631,"eighty":29.353761,"marketCap":556471590},{"date":"2025-01-10","current":-2.618383,"twenty":-0.515398,"median":9.68139,"eighty":28.675525,"marketCap":546718436},{"date":"2025-01-17","current":-2.587243,"twenty":-0.546642,"median":9.641614,"eighty":28.311552,"marketCap":540216334},{"date":"2025-01-24","current":-2.979092,"twenty":-0.561746,"median":9.598646,"eighty":27.864313,"marketCap":622034455},{"date":"2025-01-31","current":-2.883076,"twenty":-0.580286,"median":9.54256,"eighty":27.161263,"marketCap":601986306},{"date":"2025-02-07","current":-2.714399,"twenty":-0.601171,"median":9.51429,"eighty":26.337327,"marketCap":566766585},{"date":"2025-02-14","current":-2.465277,"twenty":-0.620098,"median":9.459448,"eighty":26.070105,"marketCap":514749767},{"date":"2025-02-21","current":-2.034502,"twenty":-0.64327,"median":9.438908,"eighty":25.627915,"marketCap":424804018},{"date":"2025-02-28","current":-1.83209,"twenty":-0.666065,"median":9.393833,"eighty":18.388179,"marketCap":382540353},{"date":"2025-03-07","current":-1.663757,"twenty":-0.687696,"median":9.299422,"eighty":17.111903,"marketCap":317112000},{"date":"2025-03-14","current":-1.570813,"twenty":-0.699214,"median":9.260118,"eighty":16.559512,"marketCap":299397013},{"date":"2025-03-21","current":-1.633532,"twenty":-0.754323,"median":9.210849,"eighty":16.289081,"marketCap":311351158},{"date":"2025-03-28","current":-1.402614,"twenty":-0.785037,"median":9.159558,"eighty":16.068963,"marketCap":267338167},{"date":"2025-04-04","current":-1.376956,"twenty":-0.807327,"median":9.13396,"eighty":15.873349,"marketCap":262447835},{"date":"2025-04-11","current":-1.214458,"twenty":-0.824564,"median":9.097894,"eighty":15.759337,"marketCap":231475730},{"date":"2025-04-17","current":-1.317088,"twenty":-0.839288,"median":9.076695,"eighty":15.658076,"marketCap":251037060},{"date":"2025-04-25","current":-1.530902,"twenty":-0.845914,"median":9.049045,"eighty":15.191586,"marketCap":291789829},{"date":"2025-05-02","current":-1.402614,"twenty":-0.850777,"median":9.021944,"eighty":14.679868,"marketCap":267338167},{"date":"2025-05-09","current":-2.626014,"twenty":-0.860569,"median":8.992377,"eighty":14.065031,"marketCap":345583485},{"date":"2025-05-16","current":-2.264326,"twenty":-0.870547,"median":8.947506,"eighty":13.794707,"marketCap":297985270},{"date":"2025-05-23","current":-2.680896,"twenty":-0.884562,"median":8.888998,"eighty":13.593191,"marketCap":352805875},{"date":"2025-05-30","current":-2.664398,"twenty":-0.897325,"median":8.836241,"eighty":13.254545,"marketCap":350634762},{"date":"2025-06-06","current":-2.495295,"twenty":-0.904083,"median":8.777337,"eighty":13.028751,"marketCap":328380853},{"date":"2025-06-13","current":-2.72214,"twenty":-0.916891,"median":8.734441,"eighty":12.816216,"marketCap":358233658},{"date":"2025-06-20","current":-2.602531,"twenty":-0.9304,"median":8.672186,"eighty":12.720982,"marketCap":342493088},{"date":"2025-06-27","current":-2.817003,"twenty":-0.947385,"median":8.629296,"eighty":12.560641,"marketCap":370717558},{"date":"2025-07-03","current":-2.882994,"twenty":-0.972726,"median":8.55735,"eighty":12.511814,"marketCap":379402010},{"date":"2025-07-11","current":-3.023225,"twenty":-1.003452,"median":8.539273,"eighty":12.379025,"marketCap":397856471},{"date":"2025-07-18","current":-3.002603,"twenty":-1.022475,"median":8.518611,"eighty":12.277164,"marketCap":395142580},{"date":"2025-07-25","current":-3.080968,"twenty":-1.032487,"median":8.418994,"eighty":12.18578,"marketCap":405455367},{"date":"2025-08-01","current":-2.425179,"twenty":-1.065276,"median":8.360884,"eighty":12.008607,"marketCap":319153622},{"date":"2025-08-08","current":3.151348,"twenty":-1.085009,"median":8.316278,"eighty":11.886157,"marketCap":439613055},{"date":"2025-08-15","current":3.373166,"twenty":-1.085009,"median":8.17687,"eighty":11.743548,"marketCap":470556693},{"date":"2025-08-22","current":3.564389,"twenty":-1.085009,"median":8.113226,"eighty":11.667277,"marketCap":497232242},{"date":"2025-08-29","current":3.208715,"twenty":-1.085009,"median":8.093856,"eighty":11.551925,"marketCap":447615720},{"date":"2025-09-05","current":2.918057,"twenty":-1.086865,"median":7.987875,"eighty":11.515953,"marketCap":407068885},{"date":"2025-09-12","current":3.147524,"twenty":-1.085009,"median":7.847021,"eighty":11.463178,"marketCap":439079544},{"date":"2025-09-19","current":3.036615,"twenty":-1.085009,"median":3.529969,"eighty":11.422578,"marketCap":423607726},{"date":"2025-09-26","current":3.342571,"twenty":-1.085009,"median":3.380815,"eighty":11.367054,"marketCap":466288605},{"date":"2025-10-03","current":3.514671,"twenty":-1.085009,"median":3.373166,"eighty":11.304139,"marketCap":490296599},{"date":"2025-10-10","current":3.839749,"twenty":-1.085009,"median":3.373166,"eighty":11.261022,"marketCap":535645033},{"date":"2025-10-17","current":3.594984,"twenty":-1.085009,"median":3.373166,"eighty":11.236675,"marketCap":501500330}],"updateTime":1760830456011},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EBS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554301774","title":"Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2554301774","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554301774?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:50","pubTimestamp":1753707000,"startTime":"0","endTime":"0","summary":"GAITHERSBURG, Md., July  28, 2025  (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) nal","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/28/3122490/33240/en/Emergent-Applauds-Availability-of-Over-the-Counter-Naloxone-in-U-S-House-of-Representatives.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2554566735","title":"Aptevo Therapeutics Inc. Conducted Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2554566735","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554566735?lang=en_us&edition=fundamental","pubTime":"2025-07-25 05:28","pubTimestamp":1753392537,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on July 24, 2025. The election of Marvin L. White and John E Niederhuber, M.D. to the Board of Directors was approved. The appointment of Baker Tilly US, LLP as the independent registered public accounting firm for 2025 was ratified. An amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split was approved. The issuance of more than 19.99% of the Company's outstanding Common Stock was approved. Authorization to adjourn the Special Meeting to a later date was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDL7RGcpw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4583","BK4139","APVO"],"gpt_icon":0},{"id":"2551161294","title":"Emergent BioSolutions Inc. to Announce Second Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2551161294","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551161294?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:30","pubTimestamp":1752579024,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc. will announce its second quarter 2025 financial results on August 6, 2025. The results will be released on the Investors page of Emergent's website. A conference call to discuss the results is scheduled for the same day at 5:00 pm eastern time. Participants can register in advance to join the call via telephone at this link.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original content used to generate this news brief via GlobeNewswire  on July 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL1SKXYk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU2210149790.SGD","BK4139","BK4585","BK4583","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","IE00B64PRP62.GBP","BK4588","EBS"],"gpt_icon":0},{"id":"2550666852","title":"Aptevo Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Dirk Huebner, SVP and CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2550666852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550666852?lang=en_us&edition=fundamental","pubTime":"2025-07-10 05:32","pubTimestamp":1752096766,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Dirk Huebner as the beneficial owner, holding the position of Senior Vice President and Chief Medical Officer  at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL8Jpckt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS","APVO"],"gpt_icon":0},{"id":"2550257534","title":"Emergent BioSolutions Shares Rise Over 6% After HHS Contract Modification","url":"https://stock-news.laohu8.com/highlight/detail?id=2550257534","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550257534?lang=en_us&edition=fundamental","pubTime":"2025-07-09 05:13","pubTimestamp":1752009180,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions shares rose in late trading Tuesday after the company said it received a $51.9 million government contract modification as part of the U. S. Department of Health and Human Services' smallpox preparedness.About an hour after the closing bell, shares of Emergent were trading 6.4% higher, at $7.31. The company's shares ended the day's regular session at $6.87, a gain of 3.7%.The Administration for Strategic Preparedness and Response, part of the HHS, exercised an option on an existing 10-year contract to procure additional doses of VIGIV, a treatment for complications from smallpox vaccination, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HHS","BK4009","EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2550734485","title":"Emergent BioSolutions Secures $51.9 Million Contract for Smallpox Treatment with U.S. Government","url":"https://stock-news.laohu8.com/highlight/detail?id=2550734485","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550734485?lang=en_us&edition=fundamental","pubTime":"2025-07-09 04:45","pubTimestamp":1752007537,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc. has secured a $51.9 million contract modification to supply CNJ-016 [Vaccinia Immune Globulin Intravenous ]  to the Administration for Strategic Preparedness and Response , a branch of the U.S. Department of Health and Human Services. This modification is part of an existing 10-year contract aimed at enhancing the U.S. smallpox preparedness strategy. Paul Williams, senior vice president at Emergent, emphasized the company's commitment to protecting public health by providing essential medical countermeasures. This contract follows a recent amendment for the company's Botulism Antitoxin Heptavalent  with ASPR.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDLc115pM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","BK4583","IE00BGHQF748.EUR","BK4112","EBS","IE00B3QW5Z07.USD","BK4588","NDAQ","LU2210150020.SGD","LU2095319765.USD","BK4585"],"gpt_icon":0},{"id":"2548982472","title":"Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2548982472","media":"GlobeNewswire","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548982472?lang=en_us&edition=fundamental","pubTime":"2025-07-03 04:05","pubTimestamp":1751486700,"startTime":"0","endTime":"0","summary":"Starting July 1, 2025, additional opioid overdose response tools will be available to continue addressing evolving patient and customer needs to combat public health crisisGAITHERSBURG, Md., July  02,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/02/3109517/33240/en/Emergent-BioSolutions-Expands-NARCANDirect-to-Offer-KLOXXADO-naloxone-HCl-Nasal-Spray-8-mg-and-Convenience-Kits-Amid-Changes-in-Overdose-Death-Rate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDC","BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2545475284","title":"Aptevo Therapeutics Appoints Baker Tilly as New Auditor Following Moss Adams Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2545475284","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545475284?lang=en_us&edition=fundamental","pubTime":"2025-06-24 04:06","pubTimestamp":1750709168,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has announced a change in its independent registered public accounting firm following the merger of Moss Adams LLP with Baker Tilly US, LLP, effective June 3, 2025. As a result, Moss Adams has resigned, and Baker Tilly has been appointed as the company's new independent auditor for the year ending December 31, 2025, effective June 23, 2025. During the transition, there were no disagreements or reportable events between Aptevo and Moss Adams concerning accounting principles or financial statement disclosures. Moss Adams has confirmed agreement with these statements in a letter to the Securities and Exchange Commission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL8fgh8s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","APVO","BK4583"],"gpt_icon":1},{"id":"2545397412","title":"BUZZ-Emergent rises as US awards additional $62.4 million for botulism treatment stockpile","url":"https://stock-news.laohu8.com/highlight/detail?id=2545397412","media":"Reuters","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545397412?lang=en_us&edition=fundamental","pubTime":"2025-06-23 21:04","pubTimestamp":1750683898,"startTime":"0","endTime":"0","summary":"BUZZ-Emergent rises as US awards additional $62.4 million for botulism treatment stockpile**  Shares of drugmaker Emergent Biosolutions EBS.N rise 2.9% to $6.40 premarket** EBS says U.S. Department of Health and Human Services has awarded it $62.4 million through contract modification to stockpile co's botulism treatment** Modification has been made to existing 10-year contract whereby co will supply treatment called BAT** Up to last close, stock had fallen 34.9% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nL6N3SQ0JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2545358411","title":"Emergent BioSolutions Secures $62.4 Million Contract to Supply Botulism Antitoxin to U.S","url":"https://stock-news.laohu8.com/highlight/detail?id=2545358411","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545358411?lang=en_us&edition=fundamental","pubTime":"2025-06-23 20:05","pubTimestamp":1750680316,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc. has secured a $62.4 million contract modification from the Administration for Strategic Preparedness and Response, a division of the United States Department of Health and Human Services, for its Botulism Antitoxin Heptavalent . This modification is part of an existing 10-year contract and aims to bolster the U.S. biodefense supply by providing antitoxins used in treating symptomatic botulism from various botulinum neurotoxin serotypes in both adults and pediatric patients. Paul Williams, senior vice president at Emergent, emphasized the U.S. government's ongoing commitment to stockpiling BAT, highlighting the importance of medical countermeasures in protecting military and civilian populations and strengthening global emergency preparedness.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDLGXGHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","BK4583","IE00BGHQF748.EUR","BK4112","EBS","IE00B3QW5Z07.USD","BK4588","NDAQ","LU2210150020.SGD","LU2095319765.USD","BK4585"],"gpt_icon":0},{"id":"2544212718","title":"Aptevo Therapeutics Expands CD3 Portfolio with New APVO455 Candidate Targeting Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2544212718","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544212718?lang=en_us&edition=fundamental","pubTime":"2025-06-20 20:55","pubTimestamp":1750424120,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc., a clinical-stage biotechnology company, has announced the addition of a new preclinical candidate, APVO455, to its portfolio of CD3-directed therapeutics. This development expands Aptevo's focus from hematologic cancers to include solid tumors. APVO455 targets Nectin-4+ cancers and joins other molecules in Aptevo's CD3 suite, which includes mipletamig, currently in Phase 1b/2 trials for acute myeloid leukemia , and APVO442, in preclinical development for prostate cancer. The company reports that mipletamig has shown promising results, with 85% remission rates in combination with standard care for AML and no observed cytokine release syndrome in early trial cohorts. The results of APVO455's preclinical studies have not yet been presented, but Aptevo's CEO, Marvin White, expressed confidence in the candidate's potential, citing the favorable safety profile observed in the mipletamig trials.Disclaimer: This news brief was created by Public Technologies  using gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL5PQvBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","APVO","BK4139","EBS"],"gpt_icon":1},{"id":"2544912235","title":"Emergent BioSolutions Inc. Joins Russell 3000® Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2544912235","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544912235?lang=en_us&edition=fundamental","pubTime":"2025-06-20 20:13","pubTimestamp":1750421618,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc.  will be added to the Russell 3000 Index, effective after the U.S. market closes on June 27, 2025. This inclusion is part of the annual reconstitution of the Russell U.S. stock indexes, reflecting the company's positive momentum and commitment to financial stability and long-term value creation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original content used to generate this news brief via GlobeNewswire  on June 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL11LVHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4583","LU2210149790.SGD","LU2095319765.USD","IE00BKPKM429.USD","NDAQ","BK4585","IE00B3QW5Z07.USD","BK4112","BK4588","BK4139","IE00BGHQF748.EUR","EBS","LU2210150020.SGD"],"gpt_icon":0},{"id":"2544905055","title":"Aptevo Therapeutics Announces $8 Million At-the-Market Offering Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2544905055","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544905055?lang=en_us&edition=fundamental","pubTime":"2025-06-18 22:52","pubTimestamp":1750258337,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc., a clinical-stage biotechnology company specializing in immune-oncology therapeutics, has announced an $8 million offering priced at-the-market under Nasdaq rules. The company has entered into securities purchase agreements with healthcare-focused and institutional investors to purchase 2,465,000 shares of its common stock or pre-funded warrants, along with warrants to buy up to 12,325,000 additional shares. Each share is priced at $3.25 and comes with five warrants for additional shares at the same price, exercisable upon stockholder approval and expiring five years afterward. The offering is expected to close shortly, with Roth Capital Partners serving as the placement agent. Aptevo plans to utilize the net proceeds for clinical development, working capital, and general corporate needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL3tMjKK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO","BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2544974035","title":"Aptevo Therapeutics Announces Promising Phase 1b/2 Trial Results for Mipletamig in Frontline AML, Achieving 85% Remission Rate Without Added Toxicity","url":"https://stock-news.laohu8.com/highlight/detail?id=2544974035","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544974035?lang=en_us&edition=fundamental","pubTime":"2025-06-18 20:01","pubTimestamp":1750248111,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Announces Promising Phase 1b/2 Trial Results for Mipletamig in Frontline AML, Achieving 85% Remission Rate Without Added Toxicity. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL18xCyp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583","APVO"],"gpt_icon":0},{"id":"2544029990","title":"Aptevo Therapeutics Inc. Enters Standby Equity Purchase Agreement for Up to $25 Million in Common Stock Sales with Yorkville","url":"https://stock-news.laohu8.com/highlight/detail?id=2544029990","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544029990?lang=en_us&edition=fundamental","pubTime":"2025-06-18 04:16","pubTimestamp":1750191367,"startTime":"0","endTime":"0","summary":"On June 16, 2025, Aptevo Therapeutics Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD. , allowing them the right to issue and sell up to $25 million of common stock over 36 months. The shares can be purchased by Yorkville at a price equal to 96% of the lowest daily VWAP during a three-day period, subject to certain conditions. The maximum number of shares that can be sold is capped at 151,755 unless certain conditions are met. No specific transaction details or number of shares sold are provided in the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL7Qccdy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","APVO"],"gpt_icon":0},{"id":"2543684842","title":"Aptevo Therapeutics Inc. Announces Participation in BIO International Convention in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2543684842","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543684842?lang=en_us&edition=fundamental","pubTime":"2025-06-13 20:05","pubTimestamp":1749816314,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. , a clinical-stage biotechnology company, will participate in the BIO International Convention from June 16-19, 2025, in Boston, MA. The company, known for its focus on developing novel immuno-oncology therapeutics using its ADAPTIR and ADAPTIR-FLEX platform technologies, will be represented by Michelle N. Nelson, Ph.D., Director of Immunobiology, and SoYoung Kwon, SVP, General Counsel and Head of Business Development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL5Q9yzN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO","BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2539277150","title":"Emergent BioSolutions Faces Derivative Litigation Over Alleged Breaches of Fiduciary Duty and Regulatory Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2539277150","media":"Reuters","labels":["policyRegulatory","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539277150?lang=en_us&edition=fundamental","pubTime":"2025-05-31 03:37","pubTimestamp":1748633852,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc. has reached a settlement in a series of derivative actions alleging breaches of fiduciary duty by certain current and former officers and directors. The claims centered on the company's Bayview, Maryland facility, which allegedly failed to meet regulatory standards and produce safe vaccine substances. The plaintiffs argued that Emergent's leadership did not establish adequate monitoring systems and ignored warnings, including FDA inspection reports that highlighted repeated failures in quality control and manufacturing practices. The settlement resolves these allegations, with all related claims being dismissed with prejudice. The Delaware Court had previously stayed the action pending the resolution of a related securities case.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL8vGVpZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Emergent BioSolutions Faces Derivative Litigation Over Alleged Breaches of Fiduciary Duty and Regulatory Failures","news_tag":"policyRegulatory,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2539060164","title":"Director Keith Katkin Reports Disposal of Common Shares of Emergent BioSolutions Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2539060164","media":"Reuters","labels":["shareholding","merge","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539060164?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:09","pubTimestamp":1748462940,"startTime":"0","endTime":"0","summary":"Keith Katkin, a Director, reported a disposal of common shares of Emergent BioSolutions Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDLc8TSsP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Keith Katkin Reports Disposal of Common Shares of Emergent BioSolutions Inc","news_tag":"shareholding,merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583"],"gpt_icon":0},{"id":"2537617157","title":"Aptevo Therapeutics Announces 1-for-20 Reverse Stock Split Effective May 23, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537617157","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537617157?lang=en_us&edition=fundamental","pubTime":"2025-05-24 05:10","pubTimestamp":1748034638,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. announced amendments to its bylaws to effect a reverse stock split at a 1-for-20 ratio. This change, approved by the Board on May 21, 2025, was filed and became effective on May 23, 2025. The company's stock will trade on a split-adjusted basis on Nasdaq starting May 27, 2025. No fractional shares will be issued.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDLGM8xD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO","BK4139","BK4583","EBS"],"gpt_icon":0},{"id":"2537239154","title":"Emergent BioSolutions Faces Multiple Lawsuits Over Securities Fraud and Manufacturing Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=2537239154","media":"Reuters","labels":["policyRegulatory","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537239154?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:07","pubTimestamp":1748030843,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc. is currently embroiled in significant litigation following allegations of securities fraud and manufacturing failures. The company faced class action claims from stockholders in the case In re Emergent BioSolutions Inc. Securities Litigation, filed in April 2021. Additionally, in June 2021, the Lincolnshire Police Pension Fund filed a derivative complaint against certain directors and officers of Emergent, followed by a similar complaint in August 2021. The litigation centers around extensive vaccine manufacturing failures as reported by House Committees in May 2022, and related efforts to conceal these deficiencies. Settlement negotiations are ongoing, with mediation efforts taking place in early 2024. The outcome of these legal proceedings could have significant implications for Emergent's operations and reputation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL3RJMcR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Emergent BioSolutions Faces Multiple Lawsuits Over Securities Fraud and Manufacturing Failures","news_tag":"policyRegulatory,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4583","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":71,"code":"91000000","status":"200"}]}}